These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
81 related items for PubMed ID: 1626938
1. [A phase I study on a weekly schedule of DWA2114R]. Niitani H, Fukuoka M, Furusawa M, Tamura M, Hasegawa K, Kurita Y, Ariyoshi Y, Matsunaga T, Kumoi T, Kimura I. Gan To Kagaku Ryoho; 1992 Jul; 19(7):1027-32. PubMed ID: 1626938 [Abstract] [Full Text] [Related]
2. [A phase I study of DWA2114R]. Ariyoshi Y, Wakui A, Hasegawa K, Niitani H, Ogawa M, Sakai Y, Majima H, Furue H, Miyake H, Taguchi T. Gan To Kagaku Ryoho; 1992 May; 19(5):685-93. PubMed ID: 1580642 [Abstract] [Full Text] [Related]
3. [The clinical phase I study of TNP-351. The TNP-351 Research Committee]. Taguchi T, Niitani H, Furue H, Tsukagoshi S, Kanamaru R, Hasegawa K, Akazawa S, Yoneda S, Tominaga T, Sasaki T. Gan To Kagaku Ryoho; 1995 Feb; 22(2):259-71. PubMed ID: 7857102 [Abstract] [Full Text] [Related]
4. Phase I and pharmacokinetic study of the novel platinum analogue CI-973 on a 5-daily dose schedule. O'Dwyer PJ, Hudes GR, Walczak J, Schilder R, LaCreta F, Rogers B, Cohen I, Kowal C, Whitfield L, Boyd RA. Cancer Res; 1992 Dec 15; 52(24):6746-53. PubMed ID: 1458462 [Abstract] [Full Text] [Related]
5. Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer. Giaccone G, Huizing M, Postmus PE, ten Bokkel Huinink WW, Koolen M, van Zandwijk N, Vermorken JB, Beijnen JH, Dalesio O, Pinedo HM. Semin Oncol; 1995 Aug 15; 22(4 Suppl 9):78-82. PubMed ID: 7544030 [Abstract] [Full Text] [Related]
6. [A phase II study of DWA2114R, a new platinum complex for breast cancer]. Aoyama H, Kubo K, Uchino J, Hayasaka H, Asaishi K, Izuo M, Ogawa M, Majima H, Yasutomi M, Wada T. Gan To Kagaku Ryoho; 1992 Jul 15; 19(7):1033-9. PubMed ID: 1626939 [Abstract] [Full Text] [Related]
7. Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion. Sasaki Y, Amano T, Morita M, Shinkai T, Eguchi K, Tamura T, Ohe Y, Kojima A, Saijo N. Cancer Res; 1991 Mar 01; 51(5):1472-7. PubMed ID: 1997185 [Abstract] [Full Text] [Related]
8. [Phase I study of CI-898. CI-898 Study Group]. Taguchi T, Tsukagoshi S, Furue H, Niitani H, Ohta K, Ariyoshi H, Hasegawa K, Majima H, Nakao I, Yasutomi M. Gan To Kagaku Ryoho; 1991 Aug 01; 18(10):1599-612. PubMed ID: 1831340 [Abstract] [Full Text] [Related]
9. Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer. Meerpohl HG, du Bois A, Kühnle H, Lück HJ, Kreienberg R, Möbus V, Bauknecht T, Köchli O, Bochtler H, Diergarten K. Semin Oncol; 1995 Dec 01; 22(6 Suppl 15):7-12. PubMed ID: 8643973 [Abstract] [Full Text] [Related]
11. [Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)]. Ota K, Wakui A, Majima H, Niitani H, Inuyama Y, Ogawa M, Ariyoshi Y, Yoshida O, Taguchi T, Kimura I. Gan To Kagaku Ryoho; 1992 Jun 01; 19(6):855-61. PubMed ID: 1605663 [Abstract] [Full Text] [Related]
12. A phase I trial of carboplatin and etoposide for elderly (>or=75 year-old) patients with small-cell lung cancer. Fukuda M, Soda H, Soejima Y, Fukuda M, Kinoshita A, Takatani H, Kasai T, Nagashima S, Kawabata S, Doi S, Kohno S, Oka M. Cancer Chemother Pharmacol; 2006 Nov 01; 58(5):601-6. PubMed ID: 16463061 [Abstract] [Full Text] [Related]
13. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma. Edelman MJ, Meyers FJ, Houston J, Lauder I. Semin Oncol; 1997 Oct 01; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226 [Abstract] [Full Text] [Related]
14. A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer. Gillenwater HH, McCune JS, Lindley C, Faucette S, Shord S, Donahue A, Socinski MA, Stewart CF, Zamboni WC, Kirstein MN, Moore D. Cancer Invest; 2005 Oct 01; 23(6):511-9. PubMed ID: 16203659 [Abstract] [Full Text] [Related]
15. A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer. Kelly K, Pan Z, Murphy J, Huffman DH, Bunn PA. Clin Cancer Res; 1997 Jul 01; 3(7):1117-23. PubMed ID: 9815791 [Abstract] [Full Text] [Related]
16. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network. Langer CJ, Millenson M, Rosvold E, Litwin S, McAleer CA, Bonjo CA, Ozols R. Semin Oncol; 1997 Aug 01; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128 [Abstract] [Full Text] [Related]
17. Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patients. Chambers SK, Davis CA, Chambers JT, Schwartz PE, Lorber MI, Hschumacher RE. Clin Cancer Res; 1996 Oct 01; 2(10):1699-704. PubMed ID: 9816119 [Abstract] [Full Text] [Related]
18. Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934). LoRusso P, Foster BJ, Poplin E, McCormick J, Kraut M, Flaherty L, Heilbrun LK, Valdivieso M, Baker L. Clin Cancer Res; 1995 Dec 01; 1(12):1487-93. PubMed ID: 9815948 [Abstract] [Full Text] [Related]
19. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE. Semin Oncol; 1996 Apr 01; 23(2 Suppl 5):11-8. PubMed ID: 8610230 [Abstract] [Full Text] [Related]
20. Paclitaxel and carboplatin: a phase I study in advanced non-small cell lung cancer. Paccagnella A, Favaretto A, Oniga F, Ossana L. Semin Oncol; 1996 Dec 01; 23(6 Suppl 16):76-9. PubMed ID: 9007128 [Abstract] [Full Text] [Related] Page: [Next] [New Search]